Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

GHF Group real estate hedge fund doubles value in 9 months

Thursday, September 23, 2010
Opalesque Industry Update - GHF Group reported today that the unit value of their alternative investment fund in the real estate sector surpassed the 200% mark since January 2010.

The fund yielded a 43% return in 2009, and continued to benefit from low interest rates and a below-value housing market in the U.S. and Europe in 2010. In spite of slow signs of global economic recovery, the real estate fund is expected to continue outperforming most sectors this year.

Asian and European investors who represent 82% of the fund holders have portfolios that utilize equity-related strategies for diversification. The fund invests in U.S. and European capital market instruments ranging from equities, debt and derivatives with returns linked to residential and commercial real estate, utilizing long-short and relative-value strategies.

“The relative-value method takes advantage of mismatches in prices of securities across markets and long-short strategies profit from both rising and falling prices” quoted GHF Group Senior Real Estate Analyst Bruce Morton. “Originally this fund was structured to hedge inflation risks. In the second year of the global recession, however, it is now driving the value of most clients’ holdings”. Corporate website: www.ghfgroup.net

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its